Somaiya Mayur Ian
SEC CIK 1760303 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | CFO | 98.2K | — | $3.43M | 7 | 2025-01-07 | 2026-01-20 |
Most active insiders at NAMS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davidson Michael H. | CEO, Dir | $226.5K | $25.33M |
| 2 | Kooij Louise Frederika | CAO | — | $16.75M |
| 3 | Kastelein Johannes Jacob Pieter | CSO, Dir | — | $14.26M |
| 4 | Somaiya Mayur Ian | CFO | — | $3.43M |
| 5 | LANGE LOUIS G | Dir | — | $2.19M |
| 6 | Smither John W | Dir | — | $40.5K |
| 7 | Gunning Robert William | VP, Ctrl | — | — |
| 8 | van der Kamp Hilde Johanna | Dir | — | — |
| 9 | McKenna Mark C. | Dir | — | — |
| 10 | Gulfo Adele M. | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-01-22 | 2026-01-20+ | NAMS | NewAmsterdam Pharma Co N.V. | Somaiya Mayur Ian | CFO | M - OptEx | $9.26 | +100.0K | 98.2K | New | +$926.0K |
| DMT | 2026-01-22 | 2026-01-20+ | NAMS | NewAmsterdam Pharma Co N.V. | Somaiya Mayur Ian | CFO | S - Sale+OE | $32.61 | -100.0K | 117.7K | -46% | -$3.26M |
| DT | 2026-01-07 | 2026-01-07 | NAMS | NewAmsterdam Pharma Co N.V. | Somaiya Mayur Ian | CFO | A - Grant | — | +25.5K | 58.4K | +78% | — |
| DT | 2026-01-07 | 2026-01-05 | NAMS | NewAmsterdam Pharma Co N.V. | Somaiya Mayur Ian | CFO | S - Sale | $33.25 | -5,118 | 32.9K | -13% | -$170.2K |
| DMT | 2025-01-29 | 2025-01-27+ | NAMS | NewAmsterdam Pharma Co N.V. | Somaiya Mayur Ian | CFO | S - Sale+OE | — | -61.9K | 51.3K | -55% | — |
| DMT | 2025-01-29 | 2025-01-27+ | NAMS | NewAmsterdam Pharma Co N.V. | Somaiya Mayur Ian | CFO | M - OptEx | $9.26 | +61.9K | 52.9K | New | +$573.0K |
| 2025-01-07 | 2025-01-07 | NAMS | NewAmsterdam Pharma Co N.V. | Somaiya Mayur Ian | CFO | A - Grant | — | +38.0K | 38.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations